Contact
Please use this form to send email to PR contact of this press release:
Controlled Release: spotlight innovation: GLAXOSMITHKLINE'S Ocular Drug delivery
TO:
Margaret Mugema
SMi Group Ltd
+44 (0) 20 7827 6088